DNA methylation of the protein-tyro sine phosphatase SHP1 in Philadelphia (Ph) chromosome positive chronic myelogenous leukemia (CML).

被引：0
|
作者：
Hoshino, K
Yang, H
Canalli, AA
Sanchez-Gonzalez, B
Donato, N
Kantarjian, H
Issa, JP
Garcia-Manero, G
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1528
引用
收藏
页码：420A / 421A
页数：2
相关论文
共 50 条
  • [21] PHILADELPHIA-CHROMOSOME (PH) NEGATIVE CHRONIC MYELOGENOUS LEUKEMIA (CML) WITH REARRANGEMENT OF THE BREAKPOINT CLUSTER REGION (BCR-POSITIVE) - UPDATE OF 23 PATIENTS
    CORTES, J
    KANTARJIAN, H
    OBRIEN, S
    BERAN, M
    ROBERTSON, L
    KURZROCK, R
    RIOS, M
    TALPAZ, M
    BLOOD, 1993, 82 (10) : A379 - A379
  • [22] EVOLUTION OF KARYOTYPES IN PHILADELPHIA (PH1) CHROMOSOME-NEGATIVE CHRONIC MYELOGENOUS LEUKEMIA
    MINTZ, U
    VARDIMAN, J
    GOLOMB, HM
    ROWLEY, JD
    CANCER, 1979, 43 (02) : 411 - 416
  • [23] Suppression of clonal evolution in patients with Philadelphia chromosome (Ph)-positive chronic myelogenous leukemia (CML) on interferon alfa therapy (IFN-A) therapy.
    Cortes, J
    Kantarjian, H
    OBrien, S
    Beran, M
    Estey, E
    Koller, C
    Andreeff, M
    Kornblau, S
    Keating, M
    Freireich, EJ
    Talpaz, M
    BLOOD, 1996, 88 (10) : 918 - 918
  • [24] Unmaintained complete remissions (cures) among interferon treated Philadelphia positive chronic myelogenous leukemia (CML Ph1) patients
    Talpaz, M
    Kurzrock, R
    O'Brien, S
    Kantarjian, H
    BLOOD, 1998, 92 (10) : 317A - 317A
  • [25] ANALYSIS OF PROGNOSTIC FACTORS IN 303 PATIENTS (PTS) WITH PHILADELPHIA POSITIVE (PH+VE) CHRONIC MYELOGENOUS LEUKEMIA (CML)
    KANTARJIAN, H
    SMITH, T
    MCCREDIE, K
    KEATING, M
    HESTER, J
    WALTERS, R
    FREIREICH, E
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 186 - 186
  • [26] EFFICACY OF NILOTINIB IN PATIENTS (PTS) WITH NEWLY DIAGNOSED, PREVIOUSLY UNTREATED PHILADELPHIA CHROMOSOME (PH)-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA IN EARLY CHRONIC PHASE (CML-CP)
    Cortes, J.
    Jones, D.
    O'Brien, S.
    Ferrajoli, A.
    Borhtakur, G.
    Burger, J.
    Wierda, W.
    Garcia-Manero, G.
    Letvak, L.
    Kantarjian, H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 48 - 48
  • [27] CLONAL NATURE OF PHILADELPHIA CHROMOSOME-POSITIVE AND CHROMOSOME-NEGATIVE CHRONIC MYELOGENOUS LEUKEMIA BY DNA HYBRIDIZATION ANALYSES
    YOFFE, G
    CHINAULT, AC
    TALPAZ, M
    BLICK, MB
    KANTARJIAN, HM
    TAYLOR, K
    SPITZER, G
    EXPERIMENTAL HEMATOLOGY, 1987, 15 (07) : 725 - 728
  • [28] Efficacy of Nilotinib in Patients (Pts) with Newly Diagnosed, Previously Untreated Philadelphia Chromosome (Ph)-Positive Chronic Myelogenous Leukemia in Early Chronic Phase (CML-CP)
    Cortes, Jorge
    O'Brien, Susan
    Jones, Dan
    Jabbour, Elias
    Konopleva, Marina
    Ferrajoli, Alessandra
    Kadia, Tapan
    Borthakur, Gautam
    Stigliano, Denise
    Shan, Jenny
    Kantarjian, Hagop
    BLOOD, 2009, 114 (22) : 144 - 145
  • [29] DIFFERENT PATTERNS OF CHROMOSOME AND MOLECULAR BREAKAGE IN CLASSIC PH-1 CHRONIC MYELOGENOUS LEUKEMIA (CML) AND VARIANT PH-1 CML
    KODURU, P
    GOH, JC
    ALLEN, SL
    KARP, L
    JASTI, H
    DEMARCO, LC
    LICHTMAN, SM
    HEMATOLOGIC PATHOLOGY, 1991, 5 (02) : 57 - 66
  • [30] ERYTHROBLASTIC TRANSFORMATION OF PHILADELPHIA-CHROMOSOME (PH1)-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA ASSOCIATED WITH MARKED CHROMOSOMAL REARRANGEMENTS
    SADAMORI, N
    IKEDA, S
    MUTA, T
    ICHIMARU, M
    MATSUNAGA, M
    CANCER GENETICS AND CYTOGENETICS, 1981, 3 (04) : 353 - 357
12345